Literature DB >> 31594683

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).

Javier Crespo1, Agustín Albillos2, María Buti3, José Luis Calleja4, Javier García-Samaniego5, Manuel Hernández-Guerra6, Trinidad Serrano7, Juan Turnes8, Enrique Acín9, Juan Berenguer10, Marina Berenguer11, Joan Colom12, Inmaculada Fernández13, Conrado Fernández Rodríguez14, Xavier Forns15, Federico García16, Jeffrey V Lazarus17, Jose María Molero18, Esther Molina19, Fernando Pérez Escanilla20, Juan A Pineda21, Manuel Rodríguez22, Manuel Romero23, Carlos Roncero24, Pablo Saiz de la Hoya25, Gloria Sánchez Antolín26.   

Abstract

The Spanish Association for the Study of the Liver (AEEH) is convinced that the elimination of hepatitisC virus (HCV) in Spain is possible as long as we are able to use the resources and tools necessary for it. This document reflects the position of the AEEH regarding the elimination of HCV, establishing a wide range of recommendations that can be grouped into five categories: 1)Screening of HCV according to age, of the existence of classic acquisition risk factors of infection, active search of previously diagnosed patients and development of micro-elimination strategies in vulnerable populations; 2)Simplification of HCV diagnosis (one-step diagnosis and diagnosis at the point of patient care); 3)Simplification of patient treatment and improvement of care circuits; 4)Health policy measures, and, finally, 5)Establishment of HCV elimination indicators.
Copyright © 2019 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Antiviral treatment; Cirrhosis C; Cirrosis C; Cribado; Decentralised diagnosis; Diagnóstico descentralizado; Diagnóstico en un solo paso; Eliminación; Elimination; HCV; Hepatitis C; MSM; One-step diagnosis; PQID; Población vulnerable; Point of care; Prisiones; Prisons; Screening; Tratamiento antiviral; VHC; Vulnerable population

Mesh:

Year:  2019        PMID: 31594683     DOI: 10.1016/j.gastrohep.2019.09.002

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  4 in total

1.  A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid.

Authors:  José Luis Calleja; Javier García-Samaniego; Jeffrey V Lazarus; Marcela Villota-Rivas; Inmaculada Fernández; Francisco Gea; Pablo Ryan; Sonia Alonso López; Danielle Guy
Journal:  Commun Med (Lond)       Date:  2022-02-24

2.  Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts.

Authors:  Xavier Forns; Jordan J Feld; Douglas E Dylla; Stanislas Pol; Kazuaki Chayama; Jinlin Hou; Jeong Heo; Pietro Lampertico; Ashley Brown; Mark Bondin; Fernando Tatsch; Margaret Burroughs; John Marcinak; Zhenzhen Zhang; Amanda Emmett; Stuart C Gordon; Ira M Jacobson
Journal:  Adv Ther       Date:  2021-05-22       Impact factor: 3.845

3.  Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.

Authors:  Xavier Forns; Joan Colom; Montse García-Retortillo; Joan Carles Quer; Sabela Lens; Elisa Martró; Raquel Domínguez-Hernández; Miguel Ángel Casado; María Buti
Journal:  J Viral Hepat       Date:  2021-11-29       Impact factor: 3.517

4.  Hepatitis B and C screening in hospitalized patients with SARS-CoV-2 infection.

Authors:  Judith Gómez Camarero; Ester Badia Aranda; Raisa Quiñones Castro; Rosa María Saiz Chumillas; Laura Alcoba Vega; Sandra Díez Ruiz; Noemí Gómez Manero; Raquel Vinuesa Campo; Francisco Jorquera Plaza
Journal:  Gastroenterol Hepatol       Date:  2021-09-09       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.